Tag: Bavdegalutamide

Bavdegalutamide, a novel androgen receptor degrader, demonstrates clinical activity

Presented By
Dr Xin Gao, Massachusetts General Hospital, MA, USA
Trial
Phase 2, ARDENT
Conference
ASCO GU 2022
Type
Peer-reviewed article

8 April 2022 11:21
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com